Key terms

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest NVAX news

May 13 3:58pm ET Novavax (NASDAQ:NVAX) Explodes Upward 50% After Sanofi Deal May 13 11:45am ET Novavax call volume above normal and directionally bullish May 13 11:18am ET Biotech Alert: Searches spiking for these stocks today May 13 7:23am ET Novavax price target raised to $10 from $5 at TD Cowen May 10 12:34pm ET BofA upgrades Novavax to Neutral on ‘best outcome’ Sanofi pact May 10 12:29pm ET Novavax upgraded to Neutral from Underperform at BofA May 10 11:05am ET Buy Rating for Novavax Amid Strategic Sanofi Partnership and Solid Financial Prospects May 10 10:56am ET H.C. Wainwright reiterates Buy rating on Novavax after ‘landmark’ Sanofi deal May 10 9:46am ET NVAX Earnings: Novavax Soars After Mixed Q1, Sanofi Deal Boost May 10 9:24am ET Novavax upgraded to Neutral from Underweight at JPMorgan May 10 7:05am ET Options Volatility and Implied Earnings Moves Today, May 10, 2024 May 10 5:18am ET Novavax, Sanofi enter co-exclusive COVID-19 vaccine licensing agreement May 10 5:13am ET Novavax to initiate additional cost reduction program May 10 5:12am ET Novavax cuts FY24 revenue view to $400M-$600M from $800M-$1B May 10 5:07am ET Novavax reports Q1 EPS ($1.05), consensus ($1.06) May 06 6:28am ET Novavax stockholder Shah Capital issues letter against board re-election Apr 26 2:21pm ET Novavax prepared to deliver JN.1 COVID vaccine in line with WHO recommendation Apr 15 6:06am ET Shah Capital recommends to appoint two new directors to Novavax board Apr 15 5:48am ET Novavax (NASDAQ:NVAX) Jumps Amid Activist Investor Push Apr 01 8:04am ET Novavax reports data on updated COVID-19 vaccine Mar 28 9:35pm ET Upcoming Deadline to Share in Novavax, Inc. (NVAX) Class Action Settlement Mar 26 4:07pm ET Novavax discloses confidential settlement agreement with Fujifilm Mar 19 12:19am ET Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era Mar 11 9:10am ET Novavax notes Canada’s National Advisory Committee on Immunization guidance Mar 01 6:25am ET Novavax price target lowered to $19 from $35 at H.C. Wainwright Feb 29 11:25am ET Novavax call volume above normal and directionally bullish Feb 29 8:16am ET Optimistic Outlook for Novavax: Strategic Plans and Financial Health Signal Market Share Growth Potential Feb 28 9:55pm ET Maintaining Hold on Novavax: Assessing Current Performance and Future Market Penetration Strategies Feb 28 3:58pm ET Novavax says CDC advisors in favor of added COVID vaccine dose for 65 and older Feb 28 8:04am ET Novavax sees FY24 revenue $800M-$1.000B, consensus $969.56M Feb 28 8:02am ET Novavax reports Q4 EPS ($1.44), consensus (45c)

NVAX Financials

1-year income & revenue

Key terms

NVAX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

NVAX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms